Neurology and Neurosurgery - Global Neurology Academy

49-64 of 481

Evaluating Structured Interventions for Cognitive Support in MS
Evaluating Structured Interventions for Cognitive Support in MS
AudioAbstracts
Evaluating Structured Interventions for Cognitive Support in MS
Hallie Blevins, PhD
- Hallie Blevins, PhD
Iron Deposition and Cognitive Fatigue in Multiple Sclerosis
Iron Deposition and Cognitive Fatigue in Multiple Sclerosis
NeuroFrontiers
Iron Deposition and Cognitive Fatigue in Multiple Sclerosis
Optimizing Vitamin D Supplementation in MS Care
Optimizing Vitamin D Supplementation in MS Care
NeuroFrontiers
Optimizing Vitamin D Supplementation in MS Care
Vitamin D3's Effects on Inflammatory and Oxidative Biomarkers in MS
Vitamin D3's Effects on Inflammatory and Oxidative Biomarkers in MS
NeuroFrontiers
Vitamin D3's Effects on Inflammatory and Oxidative Biomarkers in MS
The Role of Neurofilament Light Chain in MS Management
The Role of Neurofilament Light Chain in MS Management
NeuroFrontiers
The Role of Neurofilament Light Chain in MS Management
Addressing the Hidden Burden of Negative Symptoms in Schizophrenia
Addressing the Hidden Burden of Negative Symptoms in Schizophrenia
NeuroFrontiers
Addressing the Hidden Burden of Negative Symptoms in Schizophrenia
Alexandria May, PharmD, BCPS; Michael Halassa, MD, PhD
- Alexandria May, PharmD, BCPS
- Michael Halassa, MD, PhD
How Muscarinic Therapies Are Redefining Schizophrenia Care
How Muscarinic Therapies Are Redefining Schizophrenia Care
NeuroFrontiers
How Muscarinic Therapies Are Redefining Schizophrenia Care
Michael Halassa, MD, PhD
- Michael Halassa, MD, PhD
Parkinson’s Research in Focus: Translating Science Into Clinical Progress
Parkinson’s Research in Focus: Translating Science Into Clinical Progress
NeuroFrontiers
Parkinson’s Research in Focus: Translating Science Into Clinical Progress
Jerome Lisk, MD, MBA, M.S., FAAN; Michael Salvatore, PhD
- Jerome Lisk, MD, MBA, M.S., FAAN
- Michael Salvatore, PhD
- Vicki Nejtek-Salvatore, PhD
Overcoming Adherence Barriers in Schizophrenia: Strategies for Lasting Stability
Overcoming Adherence Barriers in Schizophrenia: Strategies for Lasting Stability
NeuroFrontiers
Overcoming Adherence Barriers in Schizophrenia: Strategies for Lasting Stability
Charles Turck, PharmD, BCPS, BCCCP; Tushita Mayanil, MBBS (MD)
- Charles Turck, PharmD, BCPS, BCCCP
- Tushita Mayanil, MBBS (MD)
- Melanie Yabs, PharmD, MS, BCPP
Supporting Adherence in Schizophrenia: The Role of Digital and Team-Based Tools
Supporting Adherence in Schizophrenia: The Role of Digital and Team-Based Tools
NeuroFrontiers
Supporting Adherence in Schizophrenia: The Role of Digital and Team-Based Tools
Charles Turck, PharmD, BCPS, BCCCP; Hannah Brown, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Hannah Brown, MD
Detecting Schizophrenia Early: Clinical Challenges and Future Directions
Detecting Schizophrenia Early: Clinical Challenges and Future Directions
NeuroFrontiers
Detecting Schizophrenia Early: Clinical Challenges and Future Directions
Jeffrey A. Lieberman, MD
- Jeffrey A. Lieberman, MD
Beyond Symptom Control: Optimizing Functional Outcomes in Schizophrenia Care
Beyond Symptom Control: Optimizing Functional Outcomes in Schizophrenia Care
NeuroFrontiers
Beyond Symptom Control: Optimizing Functional Outcomes in Schizophrenia Care
Ashley Baker, MSN, PMHNP; Stephen Marder, MD
- Ashley Baker, MSN, PMHNP
- Stephen Marder, MD
Digital Danger: Understanding AI Psychosis in Schizophrenia
Digital Danger: Understanding AI Psychosis in Schizophrenia
On the Frontlines of Schizophrenia
Digital Danger: Understanding AI Psychosis in Schizophrenia
Alexandria May, PharmD, BCPS; Ragy R. Girgis, MD, MS
- Alexandria May, PharmD, BCPS
- Ragy R. Girgis, MD, MS
Identifying and Managing Violence Risk in Schizophrenia Care
Identifying and Managing Violence Risk in Schizophrenia Care
On the Frontlines of Schizophrenia
Identifying and Managing Violence Risk in Schizophrenia Care
Alexandria May, PharmD, BCPS; Ragy R. Girgis, MD, MS
- Alexandria May, PharmD, BCPS
- Ragy R. Girgis, MD, MS
Practical Perspectives in Myasthenia Gravis #2: Patient Stratification and Antibody Profiling—Personalizing the Disease Lens
Practical Perspectives in Myasthenia Gravis #2: Patient Stratification and Antibody Profiling—Personalizing the Disease Lens
CME/CE
Practical Perspectives in Myasthenia Gravis #2: Patient Stratification and Antibody Profiling—Personalizing the Disease Lens
Diana Castro, MD; Jonathan Strober, MD
0.25 credits
- Diana Castro, MD
- Jonathan Strober, MD
0.25 credits
Practical Perspectives in Myasthenia Gravis # 1: Diagnostic Logistics—Navigating Complexity Across Ages
Practical Perspectives in Myasthenia Gravis # 1: Diagnostic Logistics—Navigating Complexity Across Ages
CME/CE
Practical Perspectives in Myasthenia Gravis # 1: Diagnostic Logistics—Navigating Complexity Across Ages
Diana Castro, MD; Jonathan Strober, MD
0.25 credits
- Diana Castro, MD
- Jonathan Strober, MD
0.25 credits

4/9